MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-31-2026
Co-Diagnostics Operating Expenses 2011-2026 | CODX
Annual Operating Expenses Co-Diagnostics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 50.6 M | 43 M | 45.3 M | 55.7 M | 40.2 M | 16.3 M | 6 M | 6.15 M | 4.57 M | - | 1.98 M | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 55.7 M | 1.98 M | 27 M |
Quarterly Operating Expenses Co-Diagnostics
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.13 M | 8.19 M | 8.58 M | - | 10.6 M | 10.1 M | 10.5 M | - | 11.1 M | 11.7 M | 10.1 M | - | 10.9 M | 8.25 M | 9.59 M | - | 13.2 M | 13.1 M | 6.42 M | - | 3.96 M | 3.36 M | 2.15 M | - | 1.67 M | 1.39 M | 1.26 M | - | 1.67 M | 1.36 M | 1.29 M | - | 1.81 M | 703 K | 564 K | - | 392 K | 390 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 13.2 M | 390 K | 5.91 M |
Operating Expenses of other stocks in the Diagnostics research industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
58 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
1.99 B | $ 116.23 | 0.6 % | $ 35.3 B |  USA |
|
Akumin
AKU
|
778 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
77.2 M | - | -61.36 % | $ 2.46 M | USA |
 |
Aspira Women's Health
AWH
|
13.8 M | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
21.6 M | - | -13.05 % | $ 7.29 M | USA |
 |
Castle Biosciences
CSTL
|
59.5 M | $ 25.26 | 3.27 % | $ 702 M | USA |
 |
Chembio Diagnostics
CEMI
|
28.5 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
14.1 M | - | - | $ 9.42 M |  Israel |
 |
CareDx, Inc
CDNA
|
411 M | $ 21.52 | 1.37 % | $ 1.15 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
59.4 M | - | - | $ 562 M |  Britain |
 |
DermTech
DMTK
|
104 M | - | -11.32 % | $ 2.94 M | USA |
 |
Enzo Biochem
ENZ
|
47.4 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
2.47 B | - | - | $ 19.8 B | USA |
 |
Illumina
ILMN
|
3.69 B | $ 127.89 | 0.01 % | $ 20.3 B | USA |
 |
Fulgent Genetics
FLGT
|
181 M | $ 16.19 | -0.74 % | $ 490 M | USA |
 |
Global Cord Blood Corporation
CO
|
451 M | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
134 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
5.91 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
983 M | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
607 M | $ 172.96 | 1.88 % | $ 8.57 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
585 M | - | - | $ 10.7 B | USA |
 |
Guardant Health
GH
|
226 M | $ 90.69 | 2.0 % | $ 11.4 B | USA |
 |
Lantheus Holdings
LNTH
|
123 M | $ 84.36 | 0.04 % | $ 5.69 B | USA |
 |
Medpace Holdings
MEDP
|
118 M | $ 416.53 | 1.46 % | $ 12 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
24.1 M | - | -20.0 % | $ 1.06 M | USA |
 |
Heska Corporation
HSKA
|
131 M | - | - | $ 1.31 B | USA |
 |
Interpace Biosciences
IDXG
|
20 M | $ 2.0 | 1.27 % | $ 8.85 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
7.12 B | $ 27.72 | 0.91 % | $ 20 B |  Niderland |
 |
Motus GI Holdings
MOTS
|
18.6 M | - | -34.28 % | $ 263 K | Israel |
 |
Senseonics Holdings
SENS
|
61.8 M | $ 7.07 | 0.21 % | $ 295 M | USA |
 |
QIAGEN N.V.
QGEN
|
821 M | - | - | $ 10.6 B | Niderland |
 |
Neogen Corporation
NEOG
|
1.48 B | $ 9.6 | 0.58 % | $ 2.08 B | USA |
 |
Soleno Therapeutics
SLNO
|
181 M | $ 52.74 | 0.04 % | $ 2.68 B | USA |
 |
Biomerica
BMRA
|
5.64 M | $ 2.17 | 1.4 % | $ 4.98 M | USA |
 |
National Research Corporation
NRC
|
38.5 M | $ 17.26 | 0.17 % | $ 386 M | USA |
 |
ICON Public Limited Company
ICLR
|
408 M | $ 102.05 | -0.12 % | $ 8.42 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
1.87 B | $ 265.38 | 0.62 % | $ 22.1 B | USA |
 |
Thermo Fisher Scientific
TMO
|
7.15 B | $ 470.88 | 0.28 % | $ 178 B | USA |
 |
Celcuity
CELC
|
172 M | $ 125.51 | 3.7 % | $ 5.87 B | USA |
 |
Trinity Biotech plc
TRIB
|
28.3 M | $ 0.65 | 0.03 % | $ 61.9 M | Irlanda |
 |
OpGen
OPGN
|
21.9 M | - | -16.95 % | $ 1.54 M | USA |
 |
NeoGenomics
NEO
|
430 M | $ 8.43 | 1.69 % | $ 1.08 B | USA |
 |
Twist Bioscience Corporation
TWST
|
116 M | $ 60.75 | -0.31 % | $ 3.63 B | USA |
 |
Myriad Genetics
MYGN
|
964 M | $ 4.79 | 0.1 % | $ 444 M | USA |
 |
Natera
NTRA
|
258 M | $ 206.25 | 1.23 % | $ 20.3 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.46 B | $ 197.24 | 0.52 % | $ 21.9 B | USA |
 |
Invitae Corporation
NVTA
|
343 M | - | - | $ 21.2 M | USA |
 |
PerkinElmer
PKI
|
1.07 B | - | -0.91 % | $ 14.7 B | USA |